Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...

RSV infection that is managed via primary care in children under 5 years of age leads to a substantial burden for families, primary care resources, and society.

‘Are bacteria making #RSV infections worse in kids? Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, ...

Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.

Researchers say interventions to reduce RSV infections, like vaccines and monoclonal antibodies, could aid antibiotic ...

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

In the 2022-23 respiratory virus season, 379,300 people in the United State were hospitalized for influenza, with median ...

Karachi is witnessing a disturbing increase in respiratory diseases, as reported by the Sindh Health Department on Monday, as ...

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

A new study across five European countries highlights the impact of RSV on clinical outcomes, healthcare utilisation, and ...

Respiratory syncytial virus (RSV) is known to cause considerable respiratory infection-related morbidity and mortality worldwide.1,2 Estimates published in 2022 from the UK highlight the ...